INBRAIN recently achieved a major milestone with the world’s first human application of its graphene-based BCI in an ongoing clinical trial at Salford Royal Hospital in Manchester, UK.
Organizations Involved
Merck KGaA, Salford Royal Hospital
Founders
Carolina Aguilar
Company Description
INBRAIN Neuroelectronics is a BCI therapeutics company using graphene to build the least invasive and most intelligent neural platform